JAMA Cardiology
Viewpoint
April 24, 2024
Seshadri Balaji, MBBS, MRCP, PhD; Jack Rychik, MD; Jeremy P.ÌýMoore, MD, MS
online first
JAMA Cardiol. 2024; 10.1001/jamacardio.2024.0689
This Viewpoint discusses the impact of sinus node dysfunction and escape junctional rhythm associated with the Fontan procedure on patient outcomes.
JAMA Cardiology
Original Investigation
July 1, 2017
Prince J.ÌýKannankeril, MD, MSCI; Jeremy P.ÌýMoore, MD, MS; Marina Cerrone, MD; Silvia G.ÌýPriori, MD, PhD; Naomi J.ÌýKertesz, MD; Pamela S.ÌýRo, MD; Anjan S.ÌýBatra, MD; Elizabeth S.ÌýKaufman, MD; David L.ÌýFairbrother, MD; Elizabeth V.ÌýSaarel, MD; Susan P.ÌýEtheridge, MD; Ronald J.ÌýKanter, MD; Michael P.ÌýCarboni, MD; Matthew V.ÌýDzurik, MD, MSCI; Darlene Fountain, RN; Heidi Chen, PhD; E. Wesley Ely, MD, MPH; Dan M.ÌýRoden, MD; Bjorn C.ÌýKnollmann, MD, PhD
free access
JAMA Cardiol. 2017; 2(7):759-766. 10.1001/jamacardio.2017.1320
This randomized clinical trial determines whether flecainide dosed to therapeutic levels and added to β-blocker therapy is superior to β-blocker therapy alone for the prevention of exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia.